JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2001
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.67B
| $12.5M | ﹤0.01% |
436,030
+50,962
| +13% | +$1.61M |
2017 Q1
24 quarters
|
|
2002
iShares MSCI China A ETF
CNYA
$197M
| $12.5M | ﹤0.01% |
381,463
+47,494
| +14% | +$1.58M |
2020 Q1
12 quarters
|
|
|
CPRX
2003
DELISTED
Catalyst Pharmaceutical
CPRX
| $12.5M | ﹤0.01% |
751,353
-394,354
| -34% | -$6.51M |
2017 Q1
24 quarters
|
|
2004
PUT
Zillow
Z
$6.16B
| $12.5M | ﹤0.01% |
280,100
-22,500
| -7% | -$956K |
2019 Q2
15 quarters
|
|
|
TWOU
2005
DELISTED
2U Inc
TWOU
| $12.4M | ﹤0.01% |
60,579
+2,590
| +4% | +$648K |
2014 Q2
35 quarters
|
|
|
MZTI
2006
The Marzetti Company
MZTI
$2.72B
| $12.4M | ﹤0.01% |
61,294
+16,443
| +37% | +$3.2M |
2014 Q3
34 quarters
|
|
2007
Northern Oil and Gas
NOG
$2.56B
| $12.4M | ﹤0.01% |
409,329
+150,975
| +58% | +$4.7M |
2020 Q4
9 quarters
|
|
|
NVEI
2008
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $12.4M | ﹤0.01% |
285,385
-1,914
| -0.7% | -$66.7K |
2021 Q4
5 quarters
|
|
|
PARA
2009
PUT
DELISTED
Paramount Global Class B
PARA
| $12.4M | ﹤0.01% |
555,000
-484,700
| -47% | -$10.4M |
2022 Q1
4 quarters
|
|
2010
Carlyle Group
CG
$14B
| $12.4M | ﹤0.01% |
398,038
-77,914
| -16% | -$2.6M |
2013 Q2
39 quarters
|
|
2011
Piper Sandler
PIPR
$4.64B
| $12.3M | ﹤0.01% |
356,012
+146,228
| +70% | +$5.21M |
2013 Q2
39 quarters
|
|
2012
GameStop
GME
$12.7B
| $12.3M | ﹤0.01% |
535,630
+93,753
| +21% | +$1.87M |
2013 Q2
39 quarters
|
|
2013
PUT
Regeneron Pharmaceuticals
REGN
$74.8B
| $12.3M | ﹤0.01% |
15,000
+11,400
| +317% | +$8.6M |
2022 Q1
4 quarters
|
|
2014
OneSpan
OSPN
$679M
| $12.3M | ﹤0.01% |
704,235
-35,606
| -5% | -$533K |
2015 Q4
29 quarters
|
|
2015
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$880M
| $12.3M | ﹤0.01% |
422,120
+132,120
| +46% | +$3.84M |
2018 Q3
18 quarters
|
|
2016
Diodes
DIOD
$4.77B
| $12.3M | ﹤0.01% |
132,728
+21,971
| +20% | +$1.97M |
2013 Q2
39 quarters
|
|
2017
Gogo Inc
GOGO
$290M
| $12.3M | ﹤0.01% |
848,344
+25,820
| +3% | +$403K |
2016 Q3
26 quarters
|
|
2018
Coca-Cola Consolidated
COKE
$12.9B
| $12.3M | ﹤0.01% |
229,730
+11,770
| +5% | +$608K |
2016 Q4
25 quarters
|
|
|
MNK
2019
DELISTED
Mallinckrodt plc
MNK
| $12.3M | ﹤0.01% |
1,681,638
-4,450
| -0.3% | -$35.6K |
2022 Q4
1 quarter
|
|
2020
Westlake Corp
WLK
$8.26B
| $12.2M | ﹤0.01% |
105,616
-20,428
| -16% | -$2.36M |
2013 Q2
39 quarters
|
|
2021
ManpowerGroup
MAN
$2.52B
| $12.2M | ﹤0.01% |
148,373
+2,298
| +2% | +$196K |
2013 Q2
39 quarters
|
|
2022
iShares US Transportation ETF
IYT
$1.94B
| $12.2M | ﹤0.01% |
214,480
+194,324
| +964% | +$11.1M |
2013 Q2
39 quarters
|
|
|
BVH
2023
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $12.2M | ﹤0.01% |
445,794
+116,021
| +35% | +$3.45M |
2018 Q2
19 quarters
|
|
2024
Tidewater
TDW
$4.18B
| $12.2M | ﹤0.01% |
276,448
+226,623
| +455% | +$9.74M |
2013 Q2
39 quarters
|
|
|
SIRE
2025
DELISTED
Sisecam Resources LP
SIRE
| $12.2M | ﹤0.01% |
485,048
+145,754
| +43% | +$3.57M |
2021 Q3
6 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.